Device Trial Radar · NCT03580772
Persona MC vs Attune Total Knee Replacement Study
Last checked: Nov 19, 2026Latest source record: Sep 11, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
31
Actual
Start
Nov 26, 2018
Primary completion
Dec 4, 2019
Study completion May 4, 2022
Sponsor
- Lead sponsor
- University of LeedsAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Zimmer Biomet
- First posted
- Jul 9, 2018
Design
- Study type
- Observational
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This study aims to compare clinical and functional outcomes of a cohort of patients that have undergone a medial congruent TKR to a similar cohort of patients that have undergone a conventional TKR and a cohort of control participants. Our null hypothesis is that there will be no difference in the functional outcome (as assessed by gait analysis) between Attune and Persona MC TKR.
Conditions
- Knee Osteoarthritis
Interventions
Persona TKRDevice
Persona® TKR (Zimmer Biomet)
Attune TKRDevice
Attune® TKR (Depuy synthes)
Primary outcomes
What the sponsor says the trial is designed to measure.
- Knee extensor momentTime frame: Average 3 years ± 2 years post-surgery
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Chapel Allerton Hospital
Leeds, United Kingdom
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.